nach oben

Erschienen in:

01.09.2020 | Original Contribution

NAD⁺ administration decreases microvascular damage following cardiac ischemia/reperfusion by restoring autophagic flux

verfasst von: You-Jun Zhang, Mingchao Zhang, Xiaona Zhao, Kailei Shi, Maoqing Ye, Jiawen Tian, Shaofeng Guan, Weihai Ying, Xinkai Qu

Erschienen in: Basic Research in Cardiology | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Microvascular damage is a key pathological change in myocardial ischemia/reperfusion (I/R) injury. Using a rat model of myocardial I/R, our current study has provided the first evidence that nicotinamide adenine dinucleotide (NAD⁺) administration can significantly attenuate myocardial I/R-induced microvascular damage, including reduced regional blood perfusion, decreased microvessel density and integrity, and coronary microvascular endothelial cells (CMECs) injury. In studies with primary cultured CMECs under hypoxia/reoxygenation (HR) and a rat model of I/R, our results suggested that the protective effect of NAD⁺ on CMECs exposed to HR or I/R is at least partially mediated by the NAD⁺-induced restoration of autophagic flux, especially lysosomal autophagy: NAD⁺ treatment markedly induced transcription factor EB (TFEB) activation and attenuated lysosomal dysfunction in the I/R or HR-exposed cells. Collectively, our study has provided the first in vivo and in vitro evidence that NAD⁺ significantly rescued the impaired autophagic flux and cell apoptosis that was induced by I/R in rat CMECs, which is mediated in part through the action of TFEB-mediated lysosomal autophagy.

Bhuiyan MS, Pattison JS, Osinska H, James J, Gulick J, McLendon PM, Hill JA, Sadoshima J, Robbins J (2013) Enhanced autophagy ameliorates cardiac proteinopathy. J Clin Invest 12312:5284–5297. https://doi.org/10.1172/jci70877CrossRef

Botker HE, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson SM, Deshwal S, Devaux Y, Di Lisa F, Di Sante M, Efentakis P, Femmino S, Garcia-Dorado D, Giricz Z, Ibanez B, Iliodromitis E, Kaludercic N, Kleinbongard P, Neuhauser M, Ovize M, Pagliaro P, Rahbek-Schmidt M, Ruiz-Meana M, Schluter KD, Schulz R, Skyschally A, Wilder C, Yellon DM, Ferdinandy P, Heusch G (2018) Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res Cardiol 1135:39. https://doi.org/10.1007/s00395-018-0696-8CrossRef

Cui D, Sun D, Wang X, Yi L, Kulikowicz E, Reyes M, Zhu J, Yang ZJ, Jiang W, Koehler RC (2017) Impaired autophagosome clearance contributes to neuronal death in a piglet model of neonatal hypoxic-ischemic encephalopathy. Cell Death Dis 87:e2919. https://doi.org/10.1038/cddis.2017.318CrossRef

Das A, Huang GX, Bonkowski MS, Longchamp A, Li C, Schultz MB, Kim LJ, Osborne B, Joshi S, Lu Y, Trevino-Villarreal JH, Kang MJ, Hung TT, Lee B, Williams EO, Igarashi M, Mitchell JR, Wu LE, Turner N, Arany Z, Guarente L, Sinclair DA (2018) Impairment of an endothelial NAD(+)-H2S signaling network is a reversible cause of vascular aging. Cell 1731:74–89 e20. https://doi.org/10.1016/j.cell.2018.02.008CrossRef

Davidson SM, Ferdinandy P, Andreadou I, Botker HE, Heusch G, Ibanez B, Ovize M, Schulz R, Yellon DM, Hausenloy DJ, Garcia-Dorado D (2019) Multitarget strategies to reduce myocardial ischemia/reperfusion injury: JACC review topic of the week. J Am Coll Cardiol 731:89–99. https://doi.org/10.1016/j.jacc.2018.09.086CrossRef

de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, Jenkins P, Thiele H, Stone GW (2017) Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J 3847:3502–3510. https://doi.org/10.1093/eurheartj/ehx414CrossRef

Fan Y, Lu H, Liang W, Garcia-Barrio MT, Guo Y, Zhang J, Zhu T, Hao Y, Zhang J, Chen YE (2018) Endothelial TFEB (transcription factor eb) positively regulates postischemic angiogenesis. Circ Res 1227:945–957. https://doi.org/10.1161/circresaha.118.312672CrossRef

Galaup A, Gomez E, Souktani R, Durand M, Cazes A, Monnot C, Teillon J, Le Jan S, Bouleti C, Briois G, Philippe J, Pons S, Martin V, Assaly R, Bonnin P, Ratajczak P, Janin A, Thurston G, Valenzuela DM, Murphy AJ, Yancopoulos GD, Tissier R, Berdeaux A, Ghaleh B, Germain S (2012) Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation 1251:140–149. https://doi.org/10.1161/CIRCULATIONAHA.111.049072CrossRef

Gedik N, Thielmann M, Kottenberg E, Peters J, Jakob H, Heusch G, Kleinbongard P (2014) No evidence for activated autophagy in left ventricular myocardium at early reperfusion with protection by remote ischemic preconditioning in patients undergoing coronary artery bypass grafting. PLoS ONE 95:e96567. https://doi.org/10.1371/journal.pone.0096567CrossRef

10.

Godar RJ, Ma X, Liu H, Murphy JT, Weinheimer CJ, Kovacs A, Crosby SD, Saftig P, Diwan A (2015) Repetitive stimulation of autophagy-lysosome machinery by intermittent fasting preconditions the myocardium to ischemia-reperfusion injury. Autophagy 119:1537–1560. https://doi.org/10.1080/15548627.2015.1063768CrossRef

11.

Granger DN, Kvietys PR (2017) Reperfusion therapy—what's with the obstructed, leaky and broken capillaries? Pathophysiology 244:213–228. https://doi.org/10.1016/j.pathophys.2017.09.003CrossRef

12.

Han X, Tai H, Wang X, Wang Z, Zhou J, Wei X, Ding Y, Gong H, Mo C, Zhang J, Qin J, Ma Y, Huang N, Xiang R, Xiao H (2016) AMPK activation protects cells from oxidative stress-induced senescence via autophagic flux restoration and intracellular NAD(+) elevation. Aging Cell 153:416–427. https://doi.org/10.1111/acel.12446CrossRef

13.

Heusch G, Kleinbongard P, Skyschally A, Levkau B, Schulz R, Erbel R (2012) The coronary circulation in cardioprotection: more than just one confounder. Cardiovasc Res 942:237–245. https://doi.org/10.1093/cvr/cvr271CrossRef

14.

Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 1164:674–699. https://doi.org/10.1161/circresaha.116.305348CrossRef

15.

Heusch G (2016) The coronary circulation as a target of cardioprotection. Circ Res 11810:1643–1658. https://doi.org/10.1161/circresaha.116.308640CrossRef

16.

Heusch G, Gersh BJ (2017) The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 3811:774–784. https://doi.org/10.1093/eurheartj/ehw224CrossRef

17.

Heusch G (2019) Coronary microvascular obstruction: the new frontier in cardioprotection. Basic Res Cardiol 1146:45. https://doi.org/10.1007/s00395-019-0756-8CrossRef

18.

Heusch G, Kleinbongard P, Rassaf T (2019) Cardioprotection beyond infarct size reduction. Circ Res 1245:679–680. https://doi.org/10.1161/circresaha.119.314679CrossRef

19.

Hosseini L, Vafaee MS, Badalzadeh R (2019) Melatonin and nicotinamide mononucleotide attenuate myocardial ischemia/reperfusion injury via modulation of mitochondrial function and hemodynamic parameters in aged rats. J Cardiovasc Pharmacol Ther. https://doi.org/10.1177/1074248419882002PubMedCrossRef

20.

Jahania SM, Sengstock D, Vaitkevicius P, Andres A, Ito BR, Gottlieb RA, Mentzer RM Jr (2013) Activation of the homeostatic intracellular repair response during cardiac surgery. J Am Coll Surg 2164:719–726. https://doi.org/10.1016/j.jamcollsurg.2012.12.034(discussion 726-719)CrossRef

21.

Kadlec AO, Beyer AM, Ait-Aissa K, Gutterman DD (2016) Mitochondrial signaling in the vascular endothelium: beyond reactive oxygen species. Basic Res Cardiol 1113:26. https://doi.org/10.1007/s00395-016-0546-5CrossRef

22.

Kleinbongard P, Heusch G (2015) Extracellular signalling molecules in the ischaemic/reperfused heart—druggable and translatable for cardioprotection? Br J Pharmacol 1728:2010–2025. https://doi.org/10.1111/bph.12902CrossRef

23.

Lee Y, Kwon I, Jang Y, Song W, Cosio-Lima LM, Roltsch MH (2017) Potential signaling pathways of acute endurance exercise-induced cardiac autophagy and mitophagy and its possible role in cardioprotection. J Physiol Sci 676:639–654. https://doi.org/10.1007/s12576-017-0555-7CrossRef

24.

Li Y, Liang P, Jiang B, Tang Y, Liu X, Liu M, Sun H, Chen C, Hao H, Liu Z, Xiao X (2020) CARD9 promotes autophagy in cardiomyocytes in myocardial ischemia/reperfusion injury via interacting with Rubicon directly. Basic Res Cardiol 1153:29. https://doi.org/10.1007/s00395-020-0790-6CrossRef

25.

Lindsey ML, Bolli R, Canty JM Jr, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner RA, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk JE, Heusch G (2018) Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol 3144:H812–H838. https://doi.org/10.1152/ajpheart.00335.2017CrossRef

26.

Liu Y, Xue X, Zhang H, Che X, Luo J, Wang P, Xu J, Xing Z, Yuan L, Liu Y, Fu X, Su D, Sun S, Zhang H, Wu C, Yang J (2018) Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia. Autophagy. https://doi.org/10.1080/15548627.2018.1531196PubMedPubMedCentralCrossRef

27.

Ma X, Liu H, Foyil SR, Godar RJ, Weinheimer CJ, Diwan A (2012) Autophagy is impaired in cardiac ischemia-reperfusion injury. Autophagy 89:1394–1396. https://doi.org/10.4161/auto.21036CrossRef

28.

Ma X, Liu H, Foyil SR, Godar RJ, Weinheimer CJ, Hill JA, Diwan A (2012) Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 12525:3170–3181. https://doi.org/10.1161/circulationaha.111.041814CrossRef

29.

Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, Montefusco S, Scotto-Rosato A, Prezioso C, Forrester A, Settembre C, Wang W, Gao Q, Xu H, Sandri M, Rizzuto R, De Matteis MA, Ballabio A (2015) Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol 173:288–299. https://doi.org/10.1038/ncb3114CrossRef

30.

Nadtochiy SM, Wang YT, Nehrke K, Munger J, Brookes PS (2018) Cardioprotection by nicotinamide mononucleotide (NMN): Involvement of glycolysis and acidic pH. J Mol Cell Cardiol 121:155–162. https://doi.org/10.1016/j.yjmcc.2018.06.007PubMedPubMedCentralCrossRef

31.

Niccoli G, Montone RA, Ibanez B, Thiele H, Crea F, Heusch G, Bulluck H, Hausenloy DJ, Berry C, Stiermaier T, Camici PG, Eitel I (2019) Optimized treatment of ST-elevation myocardial infarction. Circ Res 1252:245–258. https://doi.org/10.1161/circresaha.119.315344CrossRef

32.

Reffelmann T, Kloner RA (2002) Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol 2833:H1099–1107. https://doi.org/10.1152/ajpheart.00270.2002CrossRef

33.

Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, Sardiello M, Rubinsztein DC, Ballabio A (2011) TFEB links autophagy to lysosomal biogenesis. Science 3326036:1429–1433. https://doi.org/10.1126/science.1204592CrossRef

34.

Wang P, Guan YF, Du H, Zhai QW, Su DF, Miao CY (2012) Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia. Autophagy 81:77–87. https://doi.org/10.4161/auto.8.1.18274CrossRef

35.

Xie M, Kong Y, Tan W, May H, Battiprolu PK, Pedrozo Z, Wang ZV, Morales C, Luo X, Cho G, Jiang N, Jessen ME, Warner JJ, Lavandero S, Gillette TG, Turer AT, Hill JA (2014) Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation 12910:1139–1151. https://doi.org/10.1161/circulationaha.113.002416CrossRef

36.

Xie Y, Jiang D, Xiao J, Fu C, Zhang Z, Ye Z, Zhang X (2018) Ischemic preconditioning attenuates ischemia/reperfusion-induced kidney injury by activating autophagy via the SGK1 signaling pathway. Cell Death Dis 93:338. https://doi.org/10.1038/s41419-018-0358-7CrossRef

37.

Yamamoto T, Byun J, Zhai P, Ikeda Y, Oka S, Sadoshima J (2014) Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS ONE 96:e98972. https://doi.org/10.1371/journal.pone.0098972CrossRef

38.

Zhang DX, Zhang JP, Hu JY, Huang YS (2016) The potential regulatory roles of NAD(+) and its metabolism in autophagy. Metabolism 654:454–462. https://doi.org/10.1016/j.metabol.2015.11.010CrossRef

39.

Zhang H, Ge S, He K, Zhao X, Wu Y, Shao Y, Wu X (2019) FoxO1 inhibits autophagosome-lysosome fusion leading to endothelial autophagic-apoptosis in diabetes. Cardiovasc Res. https://doi.org/10.1093/cvr/cvz014PubMedPubMedCentralCrossRef

40.

Zhang Y, Xu M, Xia M, Li X, Boini KM, Wang M, Gulbins E, Ratz PH, Li PL (2014) Defective autophagosome trafficking contributes to impaired autophagic flux in coronary arterial myocytes lacking CD38 gene. Cardiovasc Res 1021:68–78. https://doi.org/10.1093/cvr/cvu011CrossRef

41.

Zhang Y, Wang B, Fu X, Guan S, Han W, Zhang J, Gan Q, Fang W, Ying W, Qu X (2016) Exogenous NAD(+) administration significantly protects against myocardial ischemia/reperfusion injury in rat model. Am J Transl Res 88:3342–3350

42.

Zhou H, Wang J, Zhu P, Zhu H, Toan S, Hu S, Ren J, Chen Y (2018) NR4A1 aggravates the cardiac microvascular ischemia reperfusion injury through suppressing FUNDC1-mediated mitophagy and promoting Mff-required mitochondrial fission by CK2alpha. Basic Res Cardiol 1134:23. https://doi.org/10.1007/s00395-018-0682-1CrossRef

Titel: NAD+ administration decreases microvascular damage following cardiac ischemia/reperfusion by restoring autophagic flux
verfasst von: You-Jun Zhang
Mingchao Zhang
Xiaona Zhao
Kailei Shi
Maoqing Ye
Jiawen Tian
Shaofeng Guan
Weihai Ying
Xinkai Qu
Publikationsdatum: 01.09.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Basic Research in Cardiology / Ausgabe 5/2020
Print ISSN: 0300-8428
Elektronische ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-020-0817-z

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

NAD⁺ administration decreases microvascular damage following cardiac ischemia/reperfusion by restoring autophagic flux

Abstract

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Macrophage-mediated regulation of catecholamines in sympathetic neural remodeling after myocardial infarction

Fibroblast growth factor 23 decreases PDE4 expression in heart increasing the risk of cardiac arrhythmia; Klotho opposes these effects

Selective NADH communication from α-ketoglutarate dehydrogenase to mitochondrial transhydrogenase prevents reactive oxygen species formation under reducing conditions in the heart

Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration

Metoprolol blunts the time-dependent progression of infarct size

Cardioprotection by early metoprolol- attenuation of ischemic vs. reperfusion injury?

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie